All companies
Visit website
BETTER U
OperatingBetter U, Inc.
Healthcare · Founded 2021
Science-backed treatments for a variety of mental and physical health struggles
Post-money valuation ⓘ
$30.2M
As of Feb 2025 · from Better U Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$255,966
Across 1 round since 2024
Latest share price
$5.21
Better U Common Stock 1 offering price
Financials
FY2022–FY2024 · from SEC filings · hover any figure for its source$1.7M
$103K
2022
$4.3M
$330K
2023
$6.3M
$90K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
FY2024
Income statement
Revenue
$1,700,344
$4,304,019
$6,300,996
Cost of goods sold
$410,534
$304,700
$187,689
Gross margin
76%
93%
97%
Net income
$103,415
$329,768
$89,984
Taxes paid
$0
$91,740
$15,320
Balance sheet
Cash
$217,155
$122,268
$87,077
Accounts receivable
$0
$213,848
$505,769
Total assets
$218,277
$799,379
$1,006,131
Short-term debt
$99,802
$112,618
$133,687
Long-term debt
$0
$54,407
$0
Total liabilities
$99,802
$167,025
$133,687
Other
Headcount
—
21
21
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$30.2M
post-money
Better U Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $256K / $1.2MPost-money $30.2M
Reg CF annual-report compliance
Possibly delinquent
Filed 1 of 2 annual reports (FY2024–FY2025)
Missing: 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0002039943Share price $5.21
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.